BiliaryTractCancer near Hudson, FL

Care Philosophy: Dr Amod Sarnaik is a surgical oncologist in the Department of Cutaneous Oncology,the Immunology Program and the Melanoma Center of Excellence at Moffitt Cancer Center. In addition, Dr Sarnaik holds an appointmentof associate professor of oncology and surgery at the University of South Florida. Dr Sarnaik's primary research interest involves investigation of novel immunotherapeutic treatments for melanoma. This includes tumor-based vaccines, immune-activating antibodies, targeted inhibition of oncogenic proteins and autologous T-cell therapy. His clinical interests focus on the surgical treatment of melanoma and other cutaneous-based skin cancers, sentinel lymph node biopsy techniques, and minimizing surgically-related morbidities.

Care Philosophy: Dr Amalia Stefanou is as an Assistant Member in the Department of Gastrointestinal Oncology at Moffitt Cancer Center. Dr Stefanou previously worked at Henry Ford Medical Group/Henry Ford Hospital and Wayne State University School of Medicine, where she achieved the rank of Assistant Professor. Dr Stefanou received her MD degree from Wayne State University School of Medicine, Detroit, Michigan, and she completed a Residency in General Surgery at Henry Ford Hospital, where she served as Chief Resident. Dr Stefanou then completed a Colon and Rectal Surgery Residency Training Program at Cook County Hospital/University of Illinois, Chicago.

Care Philosophy: At Moffitt Cancer Center we are working tirelessly in the areas of patient care research and education to advance one step further in fighting cancer As a National Cancer Institute designated Comprehensive Cancer Center we are committed to the health and safety of our patients and dedicated to providing expert cancer care From enhanced quality of life to complete remission Moffitt is Florida s top choice aiming to achieve the best outcome for each patient

Care Philosophy: Dr Chung's laboratory was among the first to recognize the importance of human papillomavirus (HPV) in the etiology of certain HNC as seen in one of the four subtypes in our molecular characterization study. Specifically the research showed that the most significantly deregulated genes in the HPV-positive tumors are cell cycle regulators. These data provided evidence that HPV-positive tumors may be more sensitive to chemotherapy and molecular inhibitors that specifically target cell cycle. In addition, her research findings contributed to establish the prognostic implication of the HPV status. Patients with HPV-positive HNC have a better prognosis compared to patients with HPV-negative HNC.

Care Philosophy: The surgical oncologists of Surgical Oncology Specialists believe in the multidisciplinary approach for the management of solid organ tumors We emphasize the importance of educating our patients on all the options in cancer treatment as we work closely with medical and radiation oncologists to provide state of the art management of cancer

Care Philosophy: Dr Chatwal earned her MD at Florida State University School of Medicine. She completed her Internal Medicine Residency at Emory University School of Medicine, followed by a Hematology Oncology Fellowship at Moffitt Cancer Center and the University of South Florida Morsani College of Medicine. Dr Chatwal's clinical focus is the medical oncology management of patients with genitourinary malignancies, particularly prostate cancer. Her research focus is on prostate cancer clinical trials and outcomes. Dr Chatwal also has a practical and research interest in the important issue of provider burnout.

Biography: Dr. Puri received her MD degree from Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India. She completed an Internal Medicine Residency at the University of Connecticut School of Medicine, Farmington, followed by a Hematology and Oncology Fellowship at Moffitt Cancer Center, Tampa. Dr. Puri joins us from the Huntsman Cancer Institute at the University of Utah, Salt Lake City, where she was appointed Assistant Professor in the Division of Medical Oncology. During her time at the Huntsman Cancer Institute, she served as the Physician Leader for the Thoracic Clinical Trial Research Group; in that role, she managed the ongoing and future clinical trial portfolio. We are excited for her to partner with Dr. Andreas Saltos in the role of our Clinical Research Medical Director to drive the clinical research vision and manage our trial portfolio. Dr. Puri's clinical interests involve treating patients with thoracic malignancies including non-small cell and small cell lung cancer. Her research interests include development of clinical trials for patients with thoracic malignancies with emphasis on immunotherapy, targeted therapy, and other novel therapeutics.

Care Philosophy: Dr Peguero received his MD from Ponce School of Medicine, Puerto Rico. He completed a neurology residency at the University of South Florida, Morsani College of Medicine. After completing his residency, Dr Peguero completed a fellowship in epilepsy and EEG at Vanderbilt University School of Medicine. After his fellowship, Dr Peguero was employed at The Watson Clinic, Department of Neurology, Lakeland, Florida, where he also served as Chief of Service of Neurology at Lakeland Regional Medical Center. Dr Peguero was an Assistant Professor at Ponce School of Medicine, and most recently, he has worked in private practice. Dr Peguero's clinical interest is in General Neurology, Epilepsy and Clinical Neurophysiology.

Care Philosophy: At Florida Cancer Specialists & Research Institute you will find experienced and compassionate doctors you can trust to treat your unique cancer. Our physicians share a passion for delivering exceptional and personalized care for all forms of cancer and blood disorders, close to home. From genetic screening to immunotherapies and access to clinical trials, our top-ranked cancer experts provide the newest and most advanced treatments available increasing cure rates and extending lives. No other community-based oncology practice in Florida matches the clinical trial opportunities we offer. The majority of new cancer drugs approved for use in the U.S. in recent years were studied in clinical trials with FCS participation, prior to approval. Every interaction is focused on each patient's experience and well-being to minimize disruption to daily life. Beginning with your first appointment, our dedicated FCS team provides expert guidance and support at every step of your cancer journey.

Care Philosophy: Dr Arnold Etame is a Neurological Surgeon and Scientist specializing in Neuro-Oncology at Moffitt Cancer Center, and Associate Professor of Oncology at the University of South Florida, Morsani College of Medicine. Dr Etame has extensive expertise in the treatment of malignant gliomas notably glioblastoma (GBM) and he is part of a very small group of neurosurgeons with National Institute of Health (NIH) funding to develop impactful therapies for glioblastoma. He performs a substantial number of surgeries in eloquent and non-eloquent regions of the brain with image-guided stereotactic techniques entailing functional MRI and DTI tractography neuro-navigation.

Care Philosophy: Dr Montejo joined the Moffitt Radiation Oncology Faculty in 2013 and currently serves as the departmental section head for the gynecologic radiation oncology service and radiation oncology service at Moffitt International Plaza satellite. His clinical interests include management of lymphoma, female gynecologic and breast malignancies including application of brachytherapy and modern highly conformal image-guided external beam radiotherapy. His research interests include brachytherapy and adaptation of highly conformal image-guided external body radiosurgery techniques to gynecologic and breast malignancy applications.

Care Philosophy: Her philosophy in caring for patients is to offer the least invasive, individualized yet comprehensive treatment options she would recommend for members of her own family. Her patients remain extremely important to her and she enjoys being able to help them return to happy, fulfilling lives. In her spare time, Dr Monteiro enjoys spending time with her family, traveling, and exercise.

Care Philosophy: At Florida Cancer Specialists & Research Institute you will find experienced and compassionate doctors you can trust to treat your unique cancer. Our physicians share a passion for delivering exceptional and personalized care for all forms of cancer and blood disorders, close to home. From genetic screening to immunotherapies and access to clinical trials, our top-ranked cancer experts provide the newest and most advanced treatments available increasing cure rates and extending lives. No other community-based oncology practice in Florida matches the clinical trial opportunities we offer. The majority of new cancer drugs approved for use in the U.S. in recent years were studied in clinical trials with FCS participation, prior to approval. Every interaction is focused on each patient's experience and well-being to minimize disruption to daily life. Beginning with your first appointment, our dedicated FCS team provides expert guidance and support at every step of your cancer journey.